EQUITY ALERT: Rosen Law Firm Reminds Nymox Pharmaceutical

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
EQUITY ALERT: Rosen Law Firm Reminds Nymox Pharmaceutical Corporation Investors of Important Class Action Deadline -- NYMX

NEW YORK, Dec. 12, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock (Nasdaq: NYMX ) during the period from January 31, 2011 through November 2, 2014, of the important January 26, 2015 lead plaintiff deadline in the class action.

To join the Nymox class action, go to the website http://www.rosenlegal.com/cases-447.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

The lawsuit asserts that Nymox failed to disclose material information affecting the Phase 3 clinical trials for Nymox's proprietary drug NX-1207 for the treatment of benign prostatic hyperplasia (BPH). Specifically, the Complaint alleges that Nymox misled investors by misrepresenting or concealing: (1) that the Phase 3 trial results were not objective; (2) the difficulty in obtaining objective and measured results, (3) the small likelihood of enrolling sufficient patients for the trial; and (4) the trial had an unreasonably small chance of success.

On November 2, 2014, Nymox disclosed that its two Phase 3 studies of NX-1207 were halted because the drug failed to meets its primary endpoints for efficacy. On November 3, 2014, Nymox held an investor conference call in which it admitted it was aware of certain problems concerning the Phase 3 trials. As a result of this adverse information, Nymox's share price dropped over $4.0/share or more than 80%, damaging investors.

If you wish to join the class action at no cost go to http://www.rosenlegal.com/cases-447.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com .

Laurence Rosen, Esq. Phillip Kim, Esq. Jonathan Horne, Esq. The Rosen Law Firm P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading
Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 2

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading
Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 7

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
Morphe’s Auction Hits High Notes with Fine Jewelry

Updated Category News Views 4

Luxurious Gems Steal the Spotlight When the gavel dropped at Morphy's Fine Jewelry & Watches Auction, it set the stage for a spectacular showcase of opulent treasures. The event, highlighting 632 lots and tallying over $1.8 million in sales, left bidders buzzing in anticipation of their next chance to snag a slice of elegance. Bvlgari's Serpentine Charm In the spotlight...

Continue Reading
Strategic Move: Chimney Collective Teams with Four Winds

Updated Category News Views 4

A Partnership Fueled by Legacy and Growth In the world of brick, mortar, and flue, a big play just unfolded. Chimney Collective, flexing its investment muscle, has hitched its wagon to Four Winds Chimney, a company that's carved out quite a niche in New York's chimney scene. We're not talking about a corporate takeover here; this is about putting money where growth and...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 2

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
DIFF Eyewear Opens First Flagship Store in Charleston

Updated Category News Views 1

DIFF Eyewear: From Clicks to Bricks in Charleston Here's a tale of a brand shaking things up, jumping from the digital stratosphere right into solid ground. DIFF Eyewear has officially planted its flag in Charleston, SC, marking a bold transition from being an exclusively online player to real-world retail. October 10th rang in their first brick-and-mortar store on...

Continue Reading
Bill Evans Enhances Gateway's Wealth Management Expertise

Updated Category News Views 2

Welcome Aboard, Bill Evans Some days the financial world throws a gem your way, something worth more than a rat-race racehorse in a shattered stock rally. Meet Bill Evans, a seasoned professional stepping into the vibrant arena of Gateway Financial Partners. He’s put in 29 years around the investment block, and now he’s parking himself in Glastonbury, Connecticut, set...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading

Top 5 Most Recently Viewed Articles

Feeding Families Foundation Expands Support for Caregivers

Updated Category News Views 255

Feeding Families Foundation Expands Support for Caregivers The Feeding Families Foundation, a dedicated nonprofit, has recently announced an exciting advancement. The organization is expanding its Parent Plate Program into the Pediatric Intensive Care and Pediatric Cardiac Intensive Care Units. This initiative not only helps alleviate the burden of food insecurity for...

Continue Reading
Baird Raises Griffon Corp Price Target to $92, Outperform Rating

Updated Category News Views 62

Baird Updates Griffon Corp's Stock Projection Baird has elevated its price target on shares of Griffon Corp (NYSE: GFF) from $84.00 to $92.00. This revision to the target price comes with a maintained Outperform rating, signaling strong confidence in the company's outlook. The analyst from Baird forecasts a gradual increase in Griffon's fiscal fourth-quarter financial...

Continue Reading
Stifel Maintains Buy Rating on Confluent as Growth Accelerates

Updated Category News Views 84

Stifel Remains Confident in Confluent Inc Recently, Stifel, a well-respected financial services firm, reaffirmed its Buy rating on Confluent Inc (NASDAQ:CFLT), setting an ambitious price target of $32.00. This confirmation follows a productive dialogue with a senior data streaming expert from a leading retailer, marking their second conversation of the year. During this...

Continue Reading
Valour Launches Innovative Bittensor ETP for Nordic Investors

Updated Category News Views 115

Valour Introduces Valour Bittensor (TAO) SEK ETP Valour Inc., a subsidiary of DeFi Technologies, has made a significant impact by launching the Valour Bittensor (TAO) SEK ETP on the Spotlight Stock Market. This groundbreaking initiative marks the debut of a Bittensor ETP in the Nordic region, enhancing Valour’s portfolio of innovative digital asset offerings. With a...

Continue Reading
Peter Schiff Highlights Dangers of Trump's Foreign Policy Rhetoric

Updated Category News Views 98

Understanding the U.S. Sovereign Debt Crisis Economist Peter Schiff has expressed serious concerns regarding President Donald Trump’s aggressive foreign policy rhetoric. He emphasizes that rather than serving as mere distractions, these statements are accelerating the already perilous situation of the nation’s sovereign debt and financial stability. The Intersection...

Continue Reading